Lichen sclerosis is a chronic inflammatory skin disease that causes substan
tial discomfort and morbidity, most commonly in adult women, but also in me
n and children. Any skin site may be affected (and, rarely, the oral mucosa
) but Lichen sclerosus is most common in the anogenital area, where it caus
es intractable itching and soreness. In children, the disorder may be confu
sed with changes seen in sexual abuse. progression to destructive scarring
is common. There is increased risk of developing vulval cancer, and there a
re links with penile cancer. Patients should be kept under longterm review.
Lichen sclerosus can occur without symptoms, and the exact prevalence is u
ncertain. It occurs most commonly in women at times of low sex hormone outp
ut. The underlying cause is unknown, but there seems to be a genetic suscep
tibility and a link with autoimmune mechanisms. The wart virus and the spir
ochaete borrelia have been suggested but not substantiated as infective tri
ggers. The Koebner phenomenon is known to occur (lichen sclerosus occurs in
skin already scarred or damaged), so trauma, injury, and sexual abuse have
been suggested as possible triggers of symptoms in genetically predisposed
people. The treatment of choice for anogenital lichen sclerosus is potent
topical corticosteroid ointment for a limited time. Circumcision may be ind
icated in men, and surgery may be considered in women, to relieve effects o
f scarring or to treat coexisting carcinoma. Current research aims to ident
ify a treatable cause of lichen sclerosus, to identify patients at risk of
scarring and of malignant disorders, and to find target pathways for therap
eutic intervention.